Related Experiment Video
Updated: Feb 3, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Fulminant liver failure secondary to submassive hepatic necrosis in a patient treated with Orlistat. A case report
Luis Alberto Martínez Insfran1, Felipe Alconchel Gago2, Pascual Parrilla Paricio3
1Servicio de Cirugia General, Hospital Universitario Reina Sofía, España.
Abstract:
Orlistat is an intestinal lipase inhibitor drug that is recommended in obese patients along with a hypocaloric diet. Although the most frequent secondary effect is steatorrhea, fulminant liver failure has also been associated with this drug, which has required liver transplantation in 3 patients. We present the case of a 42-year-old obese male.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Data Reporting and Recording
Secondary Active Transport
Secondary Healthcare System
Primary and Secondary Growth in Roots and Shoots

